|
1
|
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
$159M
|
–
|
–
|
–
|
|
|
2
|
Fidelity Investments
Boston,
Massachusetts
|
$118M
|
+$84.4M
|
+1,459,434
|
+359%
|
|
|
3
|
|
$118M
|
+$496K
|
+8,579
|
+0.5%
|
|
|
4
|
|
$113M
|
–
|
–
|
–
|
|
|
5
|
Frazier Life Sciences Management
Palo Alto,
California
|
$111M
|
–
|
–
|
–
|
|
|
6
|
Paradigm Biocapital Advisors
New York
|
$95M
|
–
|
–
|
–
|
|
|
7
|
Wellington Management Group
Boston,
Massachusetts
|
$88.5M
|
-$25.7M
|
-444,821
|
-24%
|
|
|
8
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$88.4M
|
+$15.2M
|
+262,690
|
+23%
|
|
|
9
|
Janus Henderson Group
London,
|
$77.2M
|
+$27.1M
|
+467,988
|
+62%
|
|
|
10
|
Vanguard Group
Malvern,
Pennsylvania
|
$67.7M
|
+$1.08M
|
+18,716
|
+2%
|
|
|
11
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$62.4M
|
-$47M
|
-812,235
|
-45%
|
|
|
12
|
State Street
Boston,
Massachusetts
|
$48.7M
|
-$3.42M
|
-59,175
|
-7%
|
|
|
13
|
Deerfield Management
New York
|
$38.1M
|
-$24.5M
|
-422,750
|
-41%
|
|
|
14
|
Citadel Advisors
Miami,
Florida
|
$37.5M
|
+$10.4M
|
+180,247
|
+44%
|
|
|
15
|
Saturn V Capital Management
Austin,
Texas
|
$32.3M
|
-$94.6K
|
-1,635
|
-0.3%
|
|
|
16
|
TCG Crossover Management
Palo Alto,
California
|
$30.9M
|
–
|
–
|
–
|
|
|
17
|
Geode Capital Management
Boston,
Massachusetts
|
$30M
|
-$116K
|
-2,013
|
-0.4%
|
|
|
18
|
Woodline Partners
San Francisco,
California
|
$25.1M
|
+$1.13M
|
+19,538
|
+5%
|
|
|
19
|
Armistice Capital
New York
|
$22.6M
|
+$11.3M
|
+196,000
|
+123%
|
|
|
20
|
Adage Capital Partners
Boston,
Massachusetts
|
$22.2M
|
-$11.6M
|
-200,000
|
-36%
|
|
|
21
|
MPM BioImpact
Boston,
Massachusetts
|
$22M
|
+$2M
|
+34,640
|
+11%
|
|
|
22
|
Foresite Capital Management V
Larkspur,
California
|
$19M
|
–
|
–
|
–
|
|
|
23
|
Victory Capital Management
San Antonio,
Texas
|
$15M
|
+$939K
|
+16,230
|
+7%
|
|
|
24
|
Logos Global Management
San Francisco,
California
|
$12.7M
|
-$42.5M
|
-735,000
|
-79%
|
|
|
25
|
Northern Trust
Chicago,
Illinois
|
$11.9M
|
+$943K
|
+16,299
|
+10%
|
|
